Patients around the country are looking into their legal rights and the latest litigation Actos lawsuit bladder cancer 2011 news including filing deadlines based on the serious side effects from this diabetes drug. Currently no national Actos class action lawsuit covering all people diagnosed with cancer has been filed and claims are being filed individually on behalf of people who have been diagnosed with bladder cancer after taking this diabetes medication.
In June 2011 the Food and Drug Administration (FDA) published an announcement based on data from long-term studies looking at patients using Actos (generic name – pioglitazone) for management of their diabetes for an extended period of time (longer than a year). This data showed an elevated risk for developing bladder cancer in patients using the medication over one year.
The Actos lawsuit bladder cancer claims allege that the drug manufacturer was negligent in several ways including but not limited to:
• Represented that Actos and bladder cancer was rare while there were indications that an Actos bladder cancer link in some patients was more common
• Knew or should have known through studies, that patients taking Actos for an extended period of time (more than one year) increased the risk of developing bladder cancer
• Had actual knowledge or should have known that the risk of Actos bladder cancer in patients who used the drug was greater than disclosed risk in packaging warnings for Actos
• Failed to investigate the accuracy of its Actos warning label once it became aware of potential cancer side effects revealing a safety issue
• Failed to monitor all of the most recent scientific literature related to Actos side effects cancer risks
• Failed to conduct and report post market safety surveillance on Actos
• Actos was not reasonably safe as designed because the increased risk of bladder cancer outweighed the therapeutic benefits of the drug for diabetes treatment
In June 2011, the FDA approved a revised Actos medication label that updated certain patient warning information regarding the higher risk of developing bladder cancer for patients using the drug for longer than one year. In addition, the new label warning included information for patients who have a history of bladder cancer or currently have bladder cancer stating that they should not be prescribed Actos.
Actos is prescribed in several various forms including:
• Actos (pioglitazone)
• Actoplus Met (pioglitazone/metformin)
• Actoplus Met XR (pioglitazone/metformin extended-release)
• Duetact (pioglitazone/glimepiride)
Accutane Lawsuit Bladder Cancer 2011 Claims
We represent all patients diagnosed with Actos bladder cancer side effects on a contingency fee arrangement which means that there are never any legal fees or costs unless we win your case and you receive compensation. For a free no-obligation case review please call toll free or fill out our short online contact form and an Actos lawsuit bladder cancer lawyer will contact you to answer any of your questions and help explain all of your legal options. There is a limited amount of time to file a claim (referred to as statute of limitations) so please don’t hesitate to contact us as soon as possible.